Woodline Partners LP Edgewise Therapeutics, Inc. Transaction History

Woodline Partners LP

$11 Billion
Q3 2024

A detailed history of Woodline Partners LP transactions in Edgewise Therapeutics, Inc. stock. As of the latest transaction made, Woodline Partners LP holds 527,839 shares of EWTX stock, worth $15.6 Million. This represents 0.13% of its overall portfolio holdings.

Number of Shares

527,839

Previous 421,604 25.2%

Holding current value

$15.6 Million

Previous $7.59 Million 85.54%

% of portfolio

0.13%

Previous 0.08%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$15.88 - $29.5 $1.69 Million - $3.13 Million	106,235 Added 25.2%	527,839 $14.1 Million
Q2 2024 Aug 14, 2024	BUY	$15.08 - $21.23 $248,397 - $349,700	16,472 Added 4.07%	421,604 $7.59 Million
Q1 2024 May 15, 2024	BUY	$9.25 - $19.97 $8,510 - $18,372	920 Added 0.23%	405,132 $7.39 Million
Q4 2023 Feb 14, 2024	BUY	$5.51 - $12.1 $243,095 - $533,839	44,119 Added 12.25%	404,212 $4.42 Million
Q1 2023 May 15, 2023	BUY	$6.66 - $11.33 $13 - $22	2 Added 0.0%	360,093 $2.4 Million
Q4 2022 Feb 14, 2023	SELL	$7.58 - $11.08 $1.36 Million - $1.99 Million	-179,773 Reduced 33.3%	360,091 $3.22 Million
Q3 2022 Nov 14, 2022	SELL	$8.08 - $13.58 $1.87 Million - $3.15 Million	-231,933 Reduced 30.05%	539,864 $5.31 Million
Q2 2022 Aug 15, 2022	BUY	$5.67 - $9.87 $2.33 Million - $4.06 Million	411,704 Added 114.33%	771,797 $6.14 Million
Q1 2022 May 16, 2022	SELL	$9.1 - $18.97 $389,079 - $811,081	-42,756 Reduced 10.61%	360,093 $3.49 Million
Q4 2021 Feb 14, 2022	BUY	$14.41 - $22.41 $591,213 - $919,437	41,028 Added 11.34%	402,849 $6.16 Million
Q3 2021 Nov 15, 2021	BUY	$14.11 - $24.1 $103,454 - $176,701	7,332 Added 2.07%	361,821 $6.01 Million
Q2 2021 Aug 16, 2021	SELL	$21.33 - $30.25 $62,710 - $88,935	-2,940 Reduced 0.82%	354,489 $7.56 Million
Q1 2021 May 17, 2021	BUY	$30.0 - $35.99 $10.7 Million - $12.9 Million	357,429 New	357,429 $11.6 Million

Others Institutions Holding EWTX

# of Institutions

191

Shares Held

100M

Call Options Held

2.17M

Put Options Held

410K

View Full List

About Edgewise Therapeutics, Inc.

Ticker EWTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 63,171,700
Market Cap $1.87B
Description
Edgewise Therapeutics, Inc., a biopharmaceutical company, develops small molecule therapies for musculoskeletal diseases. The Company's lead product candidate, EDG-5506, is an orally administered small molecule designed to address the root cause of dystrophinopathies including Duchenne muscular dystrophy and Becker muscular dystrophy which has c...

More about EWTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Woodline Partners LP, based on Form 13F filings with the SEC.

News

Stay updated on Woodline Partners LP with notifications on news.

Account

Woodline Partners LP Edgewise Therapeutics, Inc. Transaction History